76 related articles for article (PubMed ID: 17465238)
1. The prognostic role of the STK15 T91A polymorphism and of STK15 mRNA expression in patients with urothelial cell carcinoma.
Schultz IJ; Kiemeney LA; Roelofs R; Van Aarssen Y; Babjuk M; Willems JL; Malmström PU; Swinkels DW; Witjes JA; De Kok JB
Anticancer Res; 2007; 27(2):1025-30. PubMed ID: 17465238
[TBL] [Abstract][Full Text] [Related]
2. Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy.
Denzinger S; Stoehr R; Schwarz S; Eichenseher N; Brockhoff G; Obermann EC; Knuechel R; Blaszyk H; Hartmann A; Wild PJ
Int J Oncol; 2007 Oct; 31(4):793-802. PubMed ID: 17786310
[TBL] [Abstract][Full Text] [Related]
3. Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder.
Otto W; Fritsche HM; Wild PJ; Wieland WF; Hartmann A; Burger M; Hofstädter F; Denzinger S
Pathol Res Pract; 2011 Mar; 207(3):161-3. PubMed ID: 21247708
[TBL] [Abstract][Full Text] [Related]
4. Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma; a retrospective TMA study of 246 patients with long-term follow-up.
Mhawech-Fauceglia P; Fischer G; Beck A; Cheney RT; Herrmann FR
Eur J Surg Oncol; 2006 May; 32(4):439-44. PubMed ID: 16517112
[TBL] [Abstract][Full Text] [Related]
5. Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells.
Fraizer GC; Diaz MF; Lee IL; Grossman HB; Sen S
Int J Oncol; 2004 Dec; 25(6):1631-9. PubMed ID: 15547700
[TBL] [Abstract][Full Text] [Related]
6. Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer.
Compérat E; Bièche I; Dargère D; Laurendeau I; Vieillefond A; Benoit G; Vidaud M; Camparo P; Capron F; Verret C; Cussenot O; Bedossa P; Paradis V
Urology; 2008 Oct; 72(4):873-7. PubMed ID: 18485461
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin mRNA expression analysis in evaluating the natural history of urothelial bladder cell carcinoma: results from a long-term follow-up study.
Cai T; Piazzini M; Nesi G; Taddei I; Sardi I; Detti B; Mondaini N; Dal Canto M; Bartoletti R
Oncol Rep; 2007 Apr; 17(4):925-30. PubMed ID: 17342338
[TBL] [Abstract][Full Text] [Related]
8. Expression of STK15 mRNA in hepatocellular carcinoma and its prognostic significance.
Wang R; Wang JH; Chu XY; Geng HC; Chen LB
Clin Biochem; 2009 May; 42(7-8):641-7. PubMed ID: 19232520
[TBL] [Abstract][Full Text] [Related]
9. STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis.
Royce ME; Xia W; Sahin AA; Katayama H; Johnston DA; Hortobagyi G; Sen S; Hung MC
Cancer; 2004 Jan; 100(1):12-9. PubMed ID: 14692019
[TBL] [Abstract][Full Text] [Related]
10. Expression of serine threonine kinase 15 is associated with poor differentiation in lung squamous cell carcinoma and adenocarcinoma.
Xu HT; Ma L; Qi FJ; Liu Y; Yu JH; Dai SD; Zhu JJ; Wang EH
Pathol Int; 2006 Jul; 56(7):375-80. PubMed ID: 16792546
[TBL] [Abstract][Full Text] [Related]
11. DNA damage in cytologically normal urothelial cells of patients with a history of urothelial cell carcinoma.
Gontijo AM; Marcondes JP; Elias FN; de Oliveira ML; de Lima RO; Salvadori DM; de Camargo JL
Environ Mol Mutagen; 2002; 40(3):190-9. PubMed ID: 12355553
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.
Copp HL; Chin JL; Conaway M; Theodorescu D
Cancer; 2006 Jul; 107(1):60-6. PubMed ID: 16691580
[TBL] [Abstract][Full Text] [Related]
13. Amplification/overexpression of a mitotic kinase gene in human bladder cancer.
Sen S; Zhou H; Zhang RD; Yoon DS; Vakar-Lopez F; Ito S; Jiang F; Johnston D; Grossman HB; Ruifrok AC; Katz RL; Brinkley W; Czerniak B
J Natl Cancer Inst; 2002 Sep; 94(17):1320-9. PubMed ID: 12208897
[TBL] [Abstract][Full Text] [Related]
14. Nuclear STK15 expression is associated with aggressive behaviour of oral carcinoma cells in vivo and in vitro.
Kao SY; Chen YP; Tu HF; Liu CJ; Yu AH; Wu CH; Chang KW
J Pathol; 2010 Sep; 222(1):99-109. PubMed ID: 20597069
[TBL] [Abstract][Full Text] [Related]
15. Role of the STK15 Phe31Ile polymorphism in renal cell carcinoma.
Hammerschmied CG; Stoehr R; Walter B; Wieland WF; Hartmann A; Blaszyk H; Denzinger S
Oncol Rep; 2007 Jan; 17(1):3-7. PubMed ID: 17143471
[TBL] [Abstract][Full Text] [Related]
16. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients.
Cheng L; Pan CX; Yang XJ; Lopez-Beltran A; MacLennan GT; Lin H; Kuzel TM; Papavero V; Tretiakova M; Nigro K; Koch MO; Eble JN
Cancer; 2004 Sep; 101(5):957-62. PubMed ID: 15329903
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of Rho kinases in urinary bladder cancer.
Volanis D; Zaravinos A; Kadiyska T; Delakas D; Zoumpourlis V; Spandidos DA
J BUON; 2011; 16(3):511-21. PubMed ID: 22006759
[TBL] [Abstract][Full Text] [Related]
18. [Mutation of p53 and overexpression of STK15 in laryngeal squamous-cell carcinoma].
Zhao X; Li FC; Li YH; Fu WN; Huang DF; Ye Y; Xu ZM; Sun KL
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):134-7. PubMed ID: 15946559
[TBL] [Abstract][Full Text] [Related]
19. Expression of transient receptor potential vanilloid-1 (TRPV1) in urothelial cancers of human bladder: relation to clinicopathological and molecular parameters.
Kalogris C; Caprodossi S; Amantini C; Lambertucci F; Nabissi M; Morelli MB; Farfariello V; Filosa A; Emiliozzi MC; Mammana G; Santoni G
Histopathology; 2010 Nov; 57(5):744-52. PubMed ID: 21083604
[TBL] [Abstract][Full Text] [Related]
20. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
